2m 2m 2m 2m 2m 2m 2m
Lantheus Holding (LNTH)
NASDAQ
$100.60+$0.95 (+0.96%)
Price as of Aug 03, 2026 5:57 AM EDT- $6.5BMarket Cap
- 41.19%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Lantheus Holding (LNTH)
$100.60+$0.95 (+0.96%)
LNTH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $99.64 | ||
Change | -$1.36 (-1.35%) | ||
Open | $101.03 | ||
High | $101.03 | ||
Low | $98.81 | ||
Previous Close | $101.00 | ||
Volume | 1,022,031 | ||
30-Day Average Volume | 906,764 | ||
1-Week Change | -4.94% | ||
1-Month Change | -10.19% | ||
1-Year Change | 41.19% | ||
3-Year Change | 15.20% | ||
5-Year Change | 280.74% | ||
Fundamentals | |||
Shares Outstanding | 65.1M | ||
Total Assets | $2.3B | ||
Market Cap | $6.5B | ||
Enterprise Value | $6.6B | ||
Period: QTR TTM FY | |||
Revenue | $377.3M | ||
Net Income | $118.4M | ||
Free Cash Flow | $121.9M | ||
EBIT | $160.1M | ||
EBITDA | $182.8M | ||
Net Working Capital | $609.1M | ||
EPS | $1.80 | ||
Enterprise Value/EBITDA | 36 | ||
Enterprise Value/Revenue | 17 | ||
P/B | 5 | ||
P/E | 55 | ||
PEG | 0 | ||
Price/Free Cash Flow | 53 | ||
Price/Operating Cash Flow | 52 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue